Harbin Medisan Pharmaceutical Co., Ltd.
Harbin Medisan Pharmaceutical Co., Ltd.
Share · CNE1000032V9 (XSHE)
Overview
No Price
Closing Price XSHE 28.10.2025: 13,81 CNY
28.10.2025 04:56
Current Prices from Harbin Medisan Pharmaceutical Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHE: SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
002900.SZ
CNY
28.10.2025 04:56
13,81 CNY
-0,13 CNY
-0,93 %
Share Float & Liquidity
Free Float 75,15 %
Shares Float 237,74 M
Shares Outstanding 316,36 M
Company Profile for Harbin Medisan Pharmaceutical Co., Ltd. Share
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of chemical pharmaceutical dosage forms and APIs in China. It offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, body fluid balance infusion, and other medical fields. The company was founded in 1996 and is based in Harbin, China.
Get up to date insights from finAgent about Harbin Medisan Pharmaceutical Co., Ltd.

Company Data

Name Harbin Medisan Pharmaceutical Co., Ltd.
Company Harbin Medisan Pharmaceutical Co., Ltd.
Website https://www.medisan.com.cn
Primary Exchange XSHE SHENZHEN STOCK EXCHANGE
ISIN CNE1000032V9
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Jian Fei Qin
Market Capitalization 5 Mrd.
Country China
Currency CNY
Employees 2,5 T
Address Limin Development Zone, 150025 Harbin
IPO Date 2017-09-25

Ticker Symbols

Name Symbol
SHENZHEN STOCK EXCHANGE 002900.SZ
More Shares
Investors who hold Harbin Medisan Pharmaceutical Co., Ltd. also have the following shares in their portfolio:
BIGG DIGITAL ASSETS INC
BIGG DIGITAL ASSETS INC Share
H100 GROUP AB        O.N.
H100 GROUP AB O.N. Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025